Earnings Call · Q4 FY2023·2024-02-02

Q4 23EPS +0.72%·Rev n/aQ3 23EPS +2.79%·Rev n/aQ2 23EPS +3.56%·Rev n/aQ1 23EPS -1.20%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Vice President, Investor Relations

Rick Gonzalez — Chairman of the Board and Chief Executive Officer

Rob Michael — President and Chief Operating Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Carrie Strom — Senior Vice President, AbbVie, and President, Global Allergan Aesthetics

Roopal Thakkar — Senior Vice President, Chief Medical Officer, Global Therapeutics

Scott Reents — Executive Vice President, Chief Financial Officer

+0.6%1d on move date−0.4% vs SPY3d+3.4%5d+4.3%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access